...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus.
【24h】

The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus.

机译:5-羟色胺和5-羟色胺受体拮抗剂对斑马鱼晕车病的影响。

获取原文
获取原文并翻译 | 示例

摘要

In the present study, we investigated the effect of 5-hydroxytryptamine (5-HT) and 5-HT receptor agonists and antagonists on motion sickness in Suncus murinus, and the possibility that the emetic stimulus of 5-HT can alter the sensitivity of the animals to the different emetic stimulus of motion sickness. 5-HT (1.0, 2.0, 4.0 and 8.0 mg/kg ip) induced emesis and that was antagonised by methysergide (1.0 mg/kg ip), the 5-HT(4) receptor antagonist sulphamate[1-[2-[(methylsulphonyl)amino]ethyl]-4-piperidinyl]methyl-5-fluo ro-2-methoxy-1H-indole-3-carboxylate (GR125487D; 1.0 mg/kg ip) and granisetron (0.5 mg/kg ip). Pretreatment with 5-HT caused a dose-related attenuation of the emetic response induced by a subsequent motion stimulus, which was not significantly modified by methysergide, granisetron or GR125487D pretreatment. (+)-1-(2,5-Dimethoxy-4-iodophenyl)-2-amino-propane (DOI; 0.5 and 1.0 mg/kg ip), 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT; 0.1 mg/kg ip) but not methysergide, GR125487D or granisetron, attenuated motion-induced emesis, and that was not affected by pretreatment with ketanserin (2.0 mg/kg, ip) or N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanec arboxamide trihydrocholoride (WAY-100635; 1.0 mg/kg ip), respectively. Indeed, ketanserin alone (0.1, 0.3, 1.0 and 2.0 mg/kg ip) attenuated motion sickness. These data indicate that 5-HT(1/2), 5-HT(3) and 5-HT(4) receptors are involved in the induction of 5-HT-induced emesis. However, agonist action at the 5-HT(1A/7) and 5-HT(2) receptors, and antagonist action at the 5-HT(2A) receptors can attenuate motion sickness in S. murinus.
机译:在本研究中,我们调查了5-羟色胺(5-HT)和5-HT受体激动剂和拮抗剂对桑氏动晕症的晕动病的影响,以及5-HT的催吐刺激可以改变其敏感性的可能性。动物对晕车有不同的催吐刺激。 5-HT(1.0、2.0、4.0和8.0 mg / kg ip ip)引起的呕吐,并被5-HT(4)受体拮抗剂氨基磺酸氨基甲酸酯(1.0 mg / kg ip)拮抗[1- [2-[( (甲基磺酰基)氨基]乙基] -4-哌啶基]甲基-5-氟罗-2-甲氧基-1H-吲哚-3-羧酸盐(GR125487D; 1.0 mg / kg ip)和Granisetron(0.5 mg / kg ip)。用5-HT预处理导致随后的运动刺激引起的催吐反应的剂量相关性减弱,而甲基化麦角杀菌剂,grasnisetron或GR125487D预处理并没有对其进行显着修饰。 (+)-1-(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷(DOI; 0.5和1.0 mg / kg ip ip),8-羟基-2(二正丙基氨基)四氢化萘(8 -OH-DPAT; 0.1 mg / kg ip),但未加入美塞麦肽,GR125487D或Granisetron,减退了运动诱发的呕吐,并且不受酮色林(2.0 mg / kg,ip)或N- [2- [4]预处理的影响-(2-甲氧基苯基)-1-哌嗪基]乙基] -N-(2-吡啶基)环己烷芳族酰胺三氢胆酸盐(WAY-100635; 1.0 mg / kg ip)。实际上,仅酮色林(0.1、0.3、1.0和2.0 mg / kg ip ip)可减轻晕动病。这些数据表明5-HT(1/2),5-HT(3)和5-HT(4)受体参与5-HT诱导的呕吐的诱导。但是,对5-HT(1A / 7)和5-HT(2)受体的激动剂作用以及对5-HT(2A)受体的拮抗作用可以减弱粘液链球菌的晕动病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号